Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

MARIGOLD and MitoCIAO, two searchable compendia to visualize and functionalize protein complexes during mitochondrial remodeling.

  • Rigoni, Giovanni
  • Calvo, Enrique
  • Glytsou, Christina
  • Carro-Alvarellos, Marta
  • Noguchi, Masafumi
  • Semenzato, Martina
  • Quirin, Charlotte
  • Caicci, Federico
  • Meneghetti, Natascia
  • Sturlese, Mattia
  • Ishihara, Takaya
  • Moro, Stefano
  • Rampazzo, Chiara
  • Ishihara, Naotada
  • Bezzo, Fabrizio
  • Salviati, Leonardo
  • Vazquez, Jesùs
  • Sales, Gabriele
  • Romualdi, Chiara
  • Enriquez, Jose Antonio
  • Scorrano, Luca
  • Soriano, Maria Eugenia
Mitochondrial proteins assemble dynamically in high molecular weight complexes essential for their functions. We generated and validated two searchable compendia of these mitochondrial complexes. Following identification by mass spectrometry of proteins in complexes separated using blue-native gel electrophoresis from unperturbed, cristae-remodeled, and outer membrane-permeabilized mitochondria, we created MARIGOLD, a mitochondrial apoptotic remodeling complexome database of 627 proteins. MARIGOLD elucidates how dynamically proteins distribute in complexes upon mitochondrial membrane remodeling. From MARIGOLD, we developed MitoCIAO, a mitochondrial complexes interactome tool that, by statistical correlation, calculates the likelihood of protein cooccurrence in complexes. MitoCIAO correctly predicted biologically validated interactions among components of the mitochondrial cristae organization system (MICOS) and optic atrophy 1 (OPA1) complexes. We used MitoCIAO to functionalize two ATPase family AAA domain-containing 3A (ATAD3A) complexes: one with OPA1 that regulates mitochondrial ultrastructure and the second containing ribosomal proteins that is essential for mitoribosome stability. These compendia reveal the dynamic nature of mitochondrial complexes and enable their functionalization.
Repisalud
Publicación Artículo científico (JournalArticle)

The cristae modulator Optic atrophy 1 requires mitochondrial ATP synthase oligomers to safeguard mitochondrial function

  • Quintana-Cabrera, Ruben
  • Quirin, Charlotte
  • Glytsou, Christina
  • Corrado, Mauro
  • Urbani, Andrea
  • Pellattiero, Anna
  • Calvo, Enrique
  • Vazquez, Jesus
  • Enriquez, Jose Antonio
  • Gerle, Christoph
  • Soriano, Maria Eugenia
  • Bernardi, Paolo
  • Scorrano, Luca
It is unclear how the mitochondrial fusion protein Optic atrophy 1 (OPA1), which inhibits cristae remodeling, protects from mitochondrial dysfunction. Here we identify the mitochondrial F1Fo-ATP synthase as the effector of OPA1 in mitochondrial protection. In OPA1 overexpressing cells, the loss of proton electrochemical gradient caused by respiratory chain complex III inhibition is blunted and this protection is abolished by the ATP synthase inhibitor oligomycin. Mechanistically, OPA1 and ATP synthase can interact, but recombinant OPA1 fails to promote oligomerization of purified ATP synthase reconstituted in liposomes, suggesting that OPA1 favors ATP synthase oligomerization and reversal activity by modulating cristae shape. When ATP synthase oligomers are genetically destabilized by silencing the key dimerization subunit e, OPA1 is no longer able to preserve mitochondrial function and cell viability upon complex III inhibition. Thus, OPA1 protects mitochondria from respiratory chain inhibition by stabilizing cristae shape and favoring ATP synthase oligomerization.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1

  • Herkenne, Stéphanie
  • Ek, Olivier
  • Zamberlan, Margherita
  • Pellattiero, Anna
  • Chergova, Maya
  • Chivite, Íñigo
  • Novotná, Eliška
  • Rigoni, Giovanni
  • Fonseca, Tiago Branco
  • Samardzic, Dijana
  • Agnellini, Andrielly
  • Bean, Camilla
  • Di Benedetto, Giulietta
  • Tiso, Natascia
  • Argenton, Francesco
  • Viola, Antonella
  • Soriano, Maria Eugenia
  • Giacomello, Marta
  • Ziviani, Elena
  • Sales, Gabriele
  • Claret i Carles, Marc
  • Graupera i Garcia-Milà, Mariona
  • Scorrano, Luca
While endothelial cell (EC) function is influenced by mitochondrial metabolism, the role of mitochondrial dynamics in angiogenesis, the formation of new blood vessels from existing vasculature, is unknown. Here we show that the inner mitochondrial membrane mitochondrial fusion protein optic atrophy 1 (OPA1) is required for angiogenesis. In response to angiogenic stimuli, OPA1 levels rapidly increase to limit nuclear factor kappa-light-chain-enhancer of activated B cell (NFκB) signaling, ultimately allowing angiogenic genes expression and angiogenesis. Endothelial Opa1 is indeed required in an NFκB-dependent pathway essential for developmental and tumor angiogenesis, impacting tumor growth and metastatization. A first-in-class small molecule-specific OPA1 inhibitor confirms that EC Opa1 can be pharmacologically targeted to curtail tumor growth. Our data identify Opa1 as a crucial component of physiological and tumor angiogenesis.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The cristae modulator Optic atrophy 1 requires mitochondrial ATP synthase oligomers to safeguard mitochondrial function

  • Quintana-Cabrera, Ruben
  • Quirin, Charlotte
  • Glytsou, Christina
  • Corrado, Mauro
  • Urbani, Andrea
  • Pellattiero, Anna
  • Calvo, Enrique
  • Vázquez, Jesús
  • Enríquez, José Antonio
  • Gerle, Christoph
  • Soriano, María Eugenia
  • Bernardi, Paolo
  • Scorrano, Luca
It is unclear how the mitochondrial fusion protein Optic atrophy 1 (OPA1), which inhibits cristae remodeling, protects from mitochondrial dysfunction. Here we identify the mitochondrial F1Fo-ATP synthase as the effector of OPA1 in mitochondrial protection. In OPA1 overexpressing cells, the loss of proton electrochemical gradient caused by respiratory chain complex III inhibition is blunted and this protection is abolished by the ATP synthase inhibitor oligomycin. Mechanistically, OPA1 and ATP synthase can interact, but recombinant OPA1 fails to promote oligomerization of purified ATP synthase reconstituted in liposomes, suggesting that OPA1 favors ATP synthase oligomerization and reversal activity by modulating cristae shape. When ATP synthase oligomers are genetically destabilized by silencing the key dimerization subunit e, OPA1 is no longer able to preserve mitochondrial function and cell viability upon complex III inhibition. Thus, OPA1 protects mitochondria from respiratory chain inhibition by stabilizing cristae shape and favoring ATP synthase oligomerization., R.Q.-C. was supported by an AIRC Postdoctoral Fellowship, a Fondazione Umberto Veronesi Postdoctoral Fellowship and is currently a recipient of a Juan de la Cierva-Incorporación fellowship from the Spanish Ministry of Economy, Industry and Competitiveness (IJCI-2015–26225). This work was supported by Telethon-Italy GPP10005, GGP14187, GGP15091; AIRC Italy IG-15748, ERC FP7-282280, FP7 CIG PCIG13-GA-2013-618697; Italian Ministry of Research FIRB RBAP11Z3YA_005 to L.S. C.Ge. is supported by JST, CREST Grant JPMJCR13M4 (to Genij Kurisu and C.Ge.), the Platform for Drug Design, Discovery and Development from MEXT, Japan and the Grants-in-Aid for Scientific Research (Kiban B: 17H03647) from MEXT, Japan. JAE is supported by Spanish Ministry of Economy, Industry and Competitiveness (SAF2015-65633-R; SAF2015-71521-REDC). The CNIC is supported by MINECO and Pro-CNIC Foundation and is a SO-MINECO (award SEV-2015-0505)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1

  • Herkenne, Stéphanie
  • Ek, Olivier
  • Zamberlan, Margherita
  • Pellattiero, Anna
  • Chergova, Maya
  • Chivite, Íñigo
  • Novotná, Eliška
  • Rigoni, Giovanni
  • Fonseca, Tiago Branco
  • Samardzic, Dijana
  • Agnellini, Andrielly
  • Bean, Camilla
  • Di Benedetto, Giulietta
  • Tiso, Natascia
  • Argenton, Francesco
  • Viola, Antonella
  • Soriano, Maria Eugenia
  • Giacomello, Marta
  • Ziviani, Elena
  • Sales, Gabriele
  • Claret i Carles, Marc
  • Graupera i Garcia-Milà, Mariona
  • Scorrano, Luca
While endothelial cell (EC) function is influenced by mitochondrial metabolism, the role of mitochondrial dynamics in angiogenesis, the formation of new blood vessels from existing vasculature, is unknown. Here we show that the inner mitochondrial membrane mitochondrial fusion protein optic atrophy 1 (OPA1) is required for angiogenesis. In response to angiogenic stimuli, OPA1 levels rapidly increase to limit nuclear factor kappa-light-chain-enhancer of activated B cell (NFκB) signaling, ultimately allowing angiogenic genes expression and angiogenesis. Endothelial Opa1 is indeed required in an NFκB-dependent pathway essential for developmental and tumor angiogenesis, impacting tumor growth and metastatization. A first-in-class small molecule-specific OPA1 inhibitor confirms that EC Opa1 can be pharmacologically targeted to curtail tumor growth. Our data identify Opa1 as a crucial component of physiological and tumor angiogenesis.